World Aquaculture Singapore 2026

June 2-5, 2026

Singapore

CONSERVED USE OF TETRASPANIN CD9 AS AN ENTRY RECEPTOR BYRHABDOVIRUSES SPANNING MULTIPLE GENERA

Wanwan Zhang*, Bingbing Sun, Hao Huang, Junyu Chen, Ying’ an Liang, Wenxi Li, Qinyu Peng, Ping Zhang, Zhipeng Zhan,  Xiaogang Yang, Lan Yao, Huiquan Chen, Eran Bacharach , Haifeng Li, Changjun Guo, Meisheng Yia, and Kuntong Jia

 

School of Marine Sciences

Sun Yat-Sen  University

Guangzhou, China 519000

zhangww68@mail.sysu.edu.cn



Rhabdoviruses exhibit a broad host range, yet the cellular receptors underlying their  cross-species tropism remain poorly defined. Here, we identified tetraspanin CD9 as a conserved functional entry receptor for diverse rhabdoviruses across genera, including viral hemorrhagic septicemia virus (VHSV) (Novirhabdovirus ), Siniperca chuatsi rhabdovirus (SCRV) (Siniperhavirus), and vesicular stomatitis virus (VSV) (Vesiculovirus). We demonstrated that the domain IV of VHSV glycoprotein G directly interacted with the  large extracellular loop domain of Lateolabrax japonicus CD9 (LjCD9). CD9 knockout, CD9 protein, or CD9 antibody significantly reduced VHSV infection in vitro and CD9  knockout zebrafish, while HEK293T cells, which are nonsusceptible but permissive to VHSV, become susceptible when expressing LjCD9, suggesting that LjCD9 is an entry receptor for VHSV. We further confirmed that LjCD9 functions as a functional receptor of SCRV. Importantly, the human CD9 orthologue can serve as a receptor  of VSV. Our findings also revealed that LjCD9 mediated VHSV entry via clathrinand caveolae-mediated endocytosis. Notably, nitazoxanide (NTZ) was identified as a broad-spectrum inhibitor of VHSV, SCRV, and VSV likely by interfering with the G protein–CD9 interaction. This study establishes CD9 as a cross-species receptor for rhabdoviruses and highlights NTZ as a promising broad-spectrum antiviral agent.

Rhabdoviruses infect a wide range of hosts, but the cellular  receptors enabling this crossspecies infection were unclear.  We identified the tetraspanin protein CD9 as a conserved functional entry receptor for diverse rhabdoviruses, including viral hemorrhagic septicemia  virus (VHSV), Siniperca chuatsi rhabdovirus (SCRV), and vesicular stomatitis virus (VSV). Our work shows that CD9 directly interacts with viral glycoproteins to mediate virus entry through specific endocytic pathways. Importantly, we found that  nitazoxanide (NTZ), an FDAapproved antiparasitic agent, is currently being repurposed and evaluated as an antiviral candidate against multiple rhabdoviruses. These findings reveal a shared mechanism of rhabdovirus infection across species and suggest a potential broad-spectrum antiviral strategy.